147 related articles for article (PubMed ID: 25264279)
21. [Prolonged mivacurium induced neuromuscular block in 5 patients homozygotic for atypical butyrylcholinesterase phenotype].
Burnat P; Soulard D; Jacquel A; Coste T; Le Marchand P; Benoist JF
Ann Fr Anesth Reanim; 1995; 14(6):532. PubMed ID: 8745981
[No Abstract] [Full Text] [Related]
22. Use of neuromuscular monitoring to detect prolonged effect of succinylcholine or mivacurium: three case reports.
Cassel J; Staehr-Rye AK; Nielsen CV; Gätke MR
Acta Anaesthesiol Scand; 2014 Sep; 58(8):1040-3. PubMed ID: 24947746
[TBL] [Abstract][Full Text] [Related]
23. [Prolonged neuromuscular block in a patient with butyrylcholinesterase deficiency].
Mabboux I; Hary B; Courcelle S; Ceppa F; Delacour H
Arch Pediatr; 2016 May; 23(5):497-500. PubMed ID: 27017361
[TBL] [Abstract][Full Text] [Related]
24. Pseudocholinesterase-mediated hydrolysis is superior to neostigmine for reversal of mivacurium-induced paralysis in vitro.
Yang HS; Goudsouzian N; Martyn JA
Anesthesiology; 1996 Apr; 84(4):936-44. PubMed ID: 8638849
[TBL] [Abstract][Full Text] [Related]
25. A novel mutation in the BCHE gene and phenotype identified in a child with low butyrylcholinesterase activity: a case report.
Yu R; Guo Y; Dan Y; Tan W; Mao Q; Deng G
BMC Med Genet; 2018 Apr; 19(1):58. PubMed ID: 29631548
[TBL] [Abstract][Full Text] [Related]
26. Computer-designed active human butyrylcholinesterase double mutant with a new catalytic triad.
Grigorenko BL; Novichkova DA; Lushchekina SV; Zueva IV; Schopfer LM; Nemukhin AV; Varfolomeev SD; Lockridge O; Masson P
Chem Biol Interact; 2019 Jun; 306():138-146. PubMed ID: 31009643
[TBL] [Abstract][Full Text] [Related]
27. Substrate selectivity of high-activity mutants of human butyrylcholinesterase.
Hou S; Xue L; Yang W; Fang L; Zheng F; Zhan CG
Org Biomol Chem; 2013 Nov; 11(43):7477-85. PubMed ID: 24077614
[TBL] [Abstract][Full Text] [Related]
28. Neuromuscular effects of mivacurium in 2- to 12-yr-old children with burn injury.
Martyn JA; Goudsouzian NG; Chang Y; Szyfelbein SK; Schwartz AE; Patel SS
Anesthesiology; 2000 Jan; 92(1):31-7. PubMed ID: 10638896
[TBL] [Abstract][Full Text] [Related]
29. [Prolonged neuromuscular block after administration of mivacurium caused by plasma psueudocholinesterase deficiency].
Kaiser E; Petit D; Quinot JF; Suppini A; Sallaberry M
Ann Fr Anesth Reanim; 1995; 14(6):505-7. PubMed ID: 8745975
[TBL] [Abstract][Full Text] [Related]
30. [Cholinesterases].
Lejus C; Blanloeil Y; Burnat P; Souron R
Ann Fr Anesth Reanim; 1998; 17(9):1122-35. PubMed ID: 9835982
[TBL] [Abstract][Full Text] [Related]
31. Mivacurium. A review of its pharmacology and therapeutic potential in general anaesthesia.
Frampton JE; McTavish D
Drugs; 1993 Jun; 45(6):1066-1089. PubMed ID: 7691494
[TBL] [Abstract][Full Text] [Related]
32. Polyol-induced activation by excess substrate of the D70G butyrylcholinesterase mutant.
Levitsky V; Xie W; Froment MT; Lockridge O; Masson P
Biochim Biophys Acta; 1999 Jan; 1429(2):422-30. PubMed ID: 9989227
[TBL] [Abstract][Full Text] [Related]
33. Genotyping the butyrylcholinesterase in patients with prolonged neuromuscular block after succinylcholine.
Levano S; Ginz H; Siegemund M; Filipovic M; Voronkov E; Urwyler A; Girard T
Anesthesiology; 2005 Mar; 102(3):531-5. PubMed ID: 15731589
[TBL] [Abstract][Full Text] [Related]
34. Anionic site interactions in human butyrylcholinesterase disrupted by two single point mutations.
Neville LF; Gnatt A; Padan R; Seidman S; Soreq H
J Biol Chem; 1990 Dec; 265(34):20735-8. PubMed ID: 2249982
[TBL] [Abstract][Full Text] [Related]
35. Mivacurium-induced prolonged neuromuscular block.
Sockalingam I; Green DW
Br J Anaesth; 1995 Feb; 74(2):234-6. PubMed ID: 7696076
[TBL] [Abstract][Full Text] [Related]
36. Naturally occurring mutation, Asp70his, in human butyrylcholinesterase.
Boeck AT; Fry DL; Sastre A; Lockridge O
Ann Clin Biochem; 2002 Mar; 39(Pt 2):154-6. PubMed ID: 11928765
[TBL] [Abstract][Full Text] [Related]
37. Rapid identification of atypical variant of plasma butyrylcholinesterase by PCR.
Ceppa F; Gidenne S; Benois A; Fontan E; Burnat P
Clin Chem Lab Med; 2002 Aug; 40(8):799-801. PubMed ID: 12392308
[TBL] [Abstract][Full Text] [Related]
38. An Indian butyrylcholinesterase variant L307P is not structurally stable: a molecular dynamics simulation study.
David SM; Venkatesan SK; Boopathy R
Chem Biol Interact; 2013 Mar; 203(1):30-5. PubMed ID: 23123771
[TBL] [Abstract][Full Text] [Related]
39. Increased plasma cholinesterase activity and mivacurium resistance: report of a family.
Naguib M; Gomaa M; Samarkandi AH; Bevan DR; Akkielah AK; Watson C; Billecke S; La Du BN
Anesth Analg; 1999 Dec; 89(6):1579-82. PubMed ID: 10589654
[No Abstract] [Full Text] [Related]
40. Effects of succinylcholine on the recovery of block produced by mivacurium in rats.
Kanyamibwa D; Tsaousi G; Karakoulas K; Thomareis O; Parlapani A; Makedou AH; Giala M
Methods Find Exp Clin Pharmacol; 2008 Apr; 30(3):187-91. PubMed ID: 18597002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]